Now Brought to you by Tritech Research Inc.
 

Search Results


Matches 1-50 of 65 found.
1 2 Next Last

Regulatory T Cells (C5)

01-Mar-2009 - 06-Mar-2009
Keystone Colorado USA
 
"Over the past few years Regulatory T cells have taken center stage in the field of immunoregulation. Several types of regulatory T cell have been described on the basis of their origin, generation and mechanism of action, with two main subsets identified: naturally occurring FOXP3+ regulatory T cells and inducible regulatory T cells. All types of regulatory T cell, by virtue of their capacity to control the intensity of effector responses, have been shown to play a major role in the control of immune responses at large. This meeting will highlight recent developments in our understanding of the molecular basis for the differentiation of naturally occurring or inducible regulatory T cells. The second goal is to discuss information on the targets, mechanism of action, recruitment and homeostasis of regulatory T cells. The third goal is to discuss recent advances in our understanding of the conditions favoring the emergence and regulation of these populations and to discuss how these findings are translated in clinical trials. "
 
Registration Deadline: 03-Nov-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

B cells in context (C3)

24-Feb-2009 - 01-Mar-2009
Taos New Mexico USA
 
"B lymphocytes play critical roles in immune responses by producing antibodies that eliminate pathogens, presenting antigens to T cells and secreting regulatory cytokines. B cells develop from hematopoietic precursors through stochastic and directed molecular events that include DNA rearrangements, epigenetic changes, and transcriptional regulation. Further differentiation is controlled by environmental factors that include interactions with hematopoietic and non-hematopoietic cells, pathogenic and non-pathogenic microorganisms, and a broad range of cytokines and chemokines. The B cell receptor repertoire is purged of self-specificity at multiple checkpoints prior to entrance into primary or memory pools. Failures in these processes can lead to autoimmune disease and lymphoid malignancy. These events involve highly choreographed cell-cell interactions and migratory behaviors. The goal of this meeting will be to ask how the various B cell microenvironments regulate the molecular events that determine B cell fate and function, and to explore how manipulation of the microenvironment can impact the immune response, autoimmunity, transformation and vaccine development. "
 
Registration Deadline: 22-Oct-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Mobilizing Cellular Immunity for Cancer Therapy

11-Jan-2009 - 16-Jan-2009
Snowbird Utah USA
 
"Studies demonstrating the role of the immune system in the development and/or prevention of cancer, and elucidating the obstacles limiting an effective immune response to progressing tumors, have suggested strategies for manipulating the immune system to promote eradication of established tumors. This meeting will bring together investigators probing innate and adaptive immune systems, as well as regulatory pathways, to provide a context for developing effective tumor immunotherapies. The major objectives will be as follows: (1) explore the dual roles that components of the immune system can play early in developing malignancies, leading to protection or tumor promotion; (2) examine the mechanisms by which immune responses can be subverted by the malignant process; (3) describe the rationale for and potential benefit of immunotherapeutic strategies currently being explored for modulating adaptive immunity to achieve therapeutic anti-tumor responses; and (4) discuss the rationale for concurrently employing multiple immunosupportive modalities to enhance immunotherapeutic strategies."
 
Registration Deadline: 16-Sep-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

"Innate, Adaptive and Regularotry Immune Responses to Intestinal Microbiota"

13-Jan-2009 - 18-Jan-2009
Taos New Mexico USA
 
"Recent studies have demonstrated the key role of mucosal defenses and immunoregulation in maintaining homeostasis in the distal intestine in concert with the commensal microbiota. This meeting discusses the latest information regarding the protective and effector innate and adaptive immune responses to the commensal intestinal microbiota that lead to mucosal homeostasis vs. chronic immune-mediated intestinal inflammation. We highlight the protective role of innate mucosal immune responses induced by ligation of toll- like receptors (TLR) to activate NF-kappaB and other signaling pathways. Mechanisms of bacterial killing by epithelial and phagocytic cells are explored. The interface of antigen presenting cell/ T cell activation leading to effector or regulatory T cell function in the intestine is examined with a particular emphasis on bacterial antigen-specific responses. Finally, biomedical applications of these basic research observations are explored. These basic and translational studies have direct implications for understanding the pathophysiology of chronic intestinal inflammation such as Crohns disease, ulcerative colitis and pouchitis and emphasize innate and adaptive immunoregulatory mechanisms that mediate mucosal homeostasis in a hostile environment. Major unresolved issues in mucosal immunology are as follows: (1) understanding how epithelial cells coexist with commensal intestinal bacteria, yet recognize the pathogenic organisms; (2) understanding how effector mechanisms in innate immune cells and T cells are appropriately downregulated; and (3) how understanding of basic immune regulation and inflammation can lead to the development of novel therapeutic agents for chronic inflammatory bowel diseases. This meeting presents state of the art lectures on the most recent research on innate, adaptive and regulatory immune responses to commensal bacteria, promotes interdisciplinary research interactions and explores several novel therapeutic approaches derived from recent pathogenic insights. "
 
Registration Deadline: 18-Sep-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Mechanotransduction in Physiology and Disease

18-Jan-2009 - 23-Jan-2009
Taos New Mexico USA
 
"Cellular responses to physical forces drive morphogenesis, regulate normal physiology, and contribute to pathogenesis of atherosclerosis, hypertension, cancer, osteoporosis and deafness among others. There has been considerable progress in recent years toward identifying molecules involved in mechanotransduction, including ion channels, cell adhesion receptors, cytoskeletal and extracellular matrix molecules. Progress has also been made toward measuring and defining in vivo forces, understanding cellular effects of forces, and understanding their roles in pathogenesis. However, much remains to be learned about molecular mechanisms of transduction and transmission, and the biological consequences. Additionally, limited communication between biologists, biophysicists, engineers and clinicians/translational researchers has slowed progress. The goals of this meeting are therefore: (1) to present major, recent advances in mechanotransduction; and (2) to foster multidisciplinary interactions. The meeting will address major mechanistic questions in the context of relevant clinical problems, integrating engineering/biophysics, cell biology, and physiology/disease into each session whenever possible."
 
Registration Deadline: 23-Sep-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Allergy and Asthma

20-Jan-2009 - 25-Jan-2009
keystone Colorado USA
 
"Allergic diseases, including asthma, affect up to one third of individuals in the developed world at some time in their lifetime, causing severe loss in the quality of life and a significant healthcare burden. Current treatments are predominantly palliative and there remains an unmet need for improved and novel treatments that provide long-term relief from disease symptoms. At this meeting, clinicians and scientists from both academic and pharmaceutical research environments will discuss: (1) risk factors for disease; (2) innate mechanisms and structural cells involved in the initiation, development and manifestations of disease; (3) effector and regulatory immune mechanisms involved in the allergic process; (4) the relationship between inflammation and structural remodeling in asthma; (5) the improvement of conventional treatments; and (6) novel emerging therapeutic strategies for the control of allergic and asthmatic disease. Opportunities for interdisciplinary interactions will be further enhanced by the concurrent meeting Fibrosis, which will share a session with this meeting. "
 
Registration Deadline: 22-Sep-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Multiple Sclerosis

21-Jan-2009 - 26-Jan-2009
Santa Fe New Mexico USA
 
"Despite important recent progress, the etiology of Multiple Sclerosis (MS) remains unknown and important therapeutic needs are unmet. This conference will discuss advances in basic pathogenetic mechanisms and emergent therapies for MS. Emphasis will be on the immunopathogenesis of MS, including mechanisms of lymphocyte activation and trafficking across the blood brain barrier, on sources of axonal pathology, and genetic risk factors. New imaging methods and therapeutic strategies that target the immune system and promote remyelination will be discussed. An important challenge in MS research is to integrate emerging insights in the basic mechanisms of myelination, autoimmune demyelination, and neurodegeneration with translational science. The goal of this meeting is to provide a broad spectrum of MS researchers with a forum to discuss recent advances, and to foster cross-disciplinary interactions and collaborations."
 
Registration Deadline: 24-Sep-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Pathogenesis and Immune Regulation in Helminth Infections

01-Feb-2009 - 05-Feb-2009
Tahoe City California USA
 
"The immunology of parasitic helminths is now attracting intense interest, due to the exciting and intricate relationship between immunity and pathogenesis, the proposed significance of regulatory immune controls in modulating both infection and disease, including allergies and autoimmunity, and the application of new molecular tools to the field situation. Currently, research aims to trace how helminths manipulate host immune cell populations, identify molecular mediators and receptor pathways involved in the host-pathogen dialogue, and design new interventions for control of infection in both human and animal contexts. This meeting will bring together scientists from many different countries (particularly those highly prevalent for helminth diseases), bridging from reductionist model systems, which offer proof of principle, to the epidemiological scale in which major insights are gained from natural infection settings. New questions from field and laboratory research will be generated, promoting the integration of different strands of inquiry and paving the way for new strategies for disease control. "
 
Registration Deadline: 30-Oct-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

TH17 Cells in Health and Disease

05-Feb-2009 - 10-Feb-2009
Vancouver British Co Canada
 
"T lymphocytes are important mediators of autoimmune diseases and their tolerance to self-antigens is tightly regulated. Regulatory T (Treg) cells maintain immune tolerance. Recently, a novel subset of CD4+ T cells that produce IL-17 (named Th17) has been identified and shown to be highly pathogenic in many autoimmune diseases. Surprisingly, there appears to be a reciprocal relationship between Th17 and Treg cells in their generation, and function. Therefore, T cell biology needs to be further re-examined in the context of molecular pathways that are required for their generation, mechanisms that are involved in their antagonism and function. The goal of this symposium is to bring the leaders in the field together to assess the increased complexity in the generation of pathogenic and regulatory T cells at the cellular, molecular and organismal levels and discuss the potential impact of these new findings on the development of treatments of human autoimmune diseases. "
 
Registration Deadline: 06-Oct-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Immunologic Memory and Host Defense

08-Feb-2009 - 13-Feb-2009
keystone Colorado USA
 
"Immune memory has a critical role in mediating protection against infections as well as potentiating certain allergic and autoimmune diseases. Hence a thorough understanding of the cellular and molecular mechanisms regulating adaptive immune memory will have important clinical application. In this regard, there has been great progress in understanding how the innate immune response influences adaptive immunity. Furthermore, improved methods to visualize immune responses in vivo, characterize the phenotypic and functional properties of adaptive immune responses and how lymphoid and non-lymphoid compartments influence the maintenance of such responses has substantially improved our understanding in this area. However, major hurdles still relate to difficulties in eliciting sustained T cell responses sufficient to mediate protection in humans with current vaccines. The goal of the meeting will be to focus on basic mechanisms for how T and B cells are programmed to induce and sustain immunity. The program is designed to integrate information from mouse, non-human primate and human studies to encompass all relevant areas related to control of memory T and B cell responses. In summary, this meeting should facilitate translational research that will impact vaccines and interventions for infectious disease, cancer and autoimmune/allergic disease. "
 
Registration Deadline: 08-Oct-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Pattern Recognition Molecules and Immune Sensors of Pathogens (Z1)

29-Mar-2009 - 03-Apr-2009
Banff Alberta Canada
 
"The discovery of evolutionarily conserved immune genes and pathways has led to an explosive discovery phase in innate immunity. These pathways include TLR, NLR, C-type lectin Receptor, and the helicase-containing anti-viral proteins. These novel pathways merge the innate and adaptive branches of immunity, and converge on a wide range of disorders including infectious diseases, inflammation and autoimmunity. All of the above have systemic effects that can affect the outcome of a wide range of diseases ranging from cancer to cardiovascular disorders. "
 
Registration Deadline: 02-Dec-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Human Immunology and Immunodeficiencies (D7)

12-May-2009 - 17-May-2009
Beijing China
 
"The study of human immunodeficiency, whether inherited or acquired, is an outstanding and illuminating approach for the understanding of human immunology. The clinical investigation of these experiments of nature provide novel insights into the physiology of immune responses. In the course of this Keystone Symposia meeting we aim to bring together experts in the three related fields of primary immunodeficiencies, complex genetics of infectious diseases, and virus-induced immunodeficiency. The immunological and clinical lessons learned from the care and investigation of patients with these conditions will be discussed. "
 
Registration Deadline: 12-Jan-2009
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

The Many Faces of Ubiquitin

11-Jan-2009 - 16-Jan-2009
Copper Mountain Colorado USA
 
"The ubiquitin (Ub) pathway controls many biological processes and determines how cells respond to growth factors, stress and genetic damage, controlling nearly every facet of a cells life and death. The covalent attachment of Ub to proteins can alter their localization, activities, and ultimate fate. One of the most intriguing features of the ubiquitin pathway is its emerging involvement in functions not directly related to protein degradation. In addition, some half-dozen related ubiquitin-like (Ubl) proteins, such as SUMO, are also revealing themselves as regulators of numerous cellular pathways. The existence of this vast and dynamic array of Ub and Ubl signals raises the central question of how specificity is achieved during conjugation, recognition, and signal transduction. Indeed, the molecular requirements for generating and recognizing various Ub signals are poorly understood and form a central unresolved issue in the field. This meeting will focus attention on the biology associated with Ub/Ubl-mediated signal transduction, including its role in human disease and cancer. The goal of this meeting is to gather a diverse array of scientists, not just ubiquitinologists, but also biologists whose work has been touched in some way by ubiquitin or ubiquitin-like pathways. By bringing together scientists from different backgrounds who work on a wide range of systems that are regulated by Ub and Ubl conjugation, this meeting will create a fertile ground for exchange of ideas on non-conventional functions for Ub and Ubl proteins in signal transduction. "
 
Registration Deadline: 16-Sep-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Therapeutic Modulation of RNA Using Oligonucleotides

08-Feb-2009 - 13-Feb-2009
lake Louise Alberta Canada
 
"The recent discoveries of the RNAi pathway in mammalian cells and the finding that oligonucleotides can activate the innate immune system through Toll-like receptors have resulted in increased interest in oligonucleotide-based therapeutics. There are two basic therapeutic approaches in which oligonucleotides are being utilized: (1) binding to RNA resulting in selective inhibition of gene expression; and (2) modulating protein function by direct binding to proteins. Although both approaches share common manufacturing, toxicology and ADME issues, oligonucleotides that are designed to bind RNA inside the cell have a fundamental different set of challenges than oligonucleotides designed to bind to proteins outside the cell. This meeting will focus on the former application. A goal of this meeting is to bring together scientists from both the basic science disciplines and applied disciplines to gain a common understanding of the attributes and challenges the technology faces. This meeting will consider basic mechanisms by which oligonucleotides can be exploited to modulate gene expression, mechanisms for distribution of oligonucleotides to tissues and within cells and how chemistry and/or formulations can improve the pharmaceutical properties of oligonucleotides. Finally recent advances in both preclinical applications and clinical results will be presented."
 
Registration Deadline: 08-Oct-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Complications of Diabetes and Obesity (J7)

24-Feb-2009 - 01-Mar-2009
Vancouver British Co USA
 
"The complications of diabetes and obesity are emerging as major health problems in the United States and world-wide. Obesity-linked complications may lead to the development of insulin resistance and, ultimately, hyperglycemia. Thus, the study of mechanisms underlying and linking these disorders holds promise for the identification of mechanism-targeted therapeutic agents. In addition to frank and often destructive recruitment of immune responses, diabetes and obesity are significantly modified by host and environment factors. Such factors as hypertension, innate aging, failure of effective pro- or anti- angiogenesis programs, genetic and epigenetic factors may influence the phenotype and outcome in diabetes and obesity. The goals of the meeting will be to integrate these concepts in close collaboration with the Dissecting the Vasculature concurrent meeting group. Beginning with the vessel, and addressing superimposed and modifying factors, this program will facilitate greater understanding of mechanisms linked to diabetes and its complications and obesity."
 
Registration Deadline: 23-Oct-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Genome Instability and DNA Repair (C6)

01-Mar-2009 - 06-Mar-2009
Taos New Mexico USA
 
"DNA damage repair and the DNA damage response overall are critical to the organism for both tumor suppression and the propagation of genomic information to subsequent generations. Tremendous advances have occurred in the last several years which have enlightened our understanding of the DNA damage response in all organisms and the derivation of genomic rearrangements, including in mouse and human. This meeting will highlight recent advances. Programmed DNA damage and its repair will be presented in sessions on the immune system and meiosis and germ cell development. Mechanisms of DNA repair will be presented in sessions on homologous recombination and non-homologous end-joining. Genomic rearrangements arising from sequence repeats and repetitive elements will also be presented."
 
Registration Deadline: 04-Nov-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Prevention of HIV/AIDS (X3)

22-Mar-2009 - 27-Mar-2009
Keystone Colorado USA
 
"Most recent research efforts on the prevention of HIV and AIDS has focused on T cell-based vaccines but it is admitted this approach will not prevent HIV and needs to be strengthened by novel approaches to generate HIV neutralizing antibodies. The recent successes or failures of alternative methods of HIV prevention (e.g., microbicides, circumcision), or of AIDS prevention (therapeutic vaccines) should help better understand how HIV vaccines can be used, and require sharing basic understanding and results with the prophylactic vaccine field. However the recent negative results of a major HIV vaccine trial have substantially disorganized the field and limit preparation of a definitive program a year and a half in advance. The goals of the meeting are therefore to focus on the most recent key advances in the understanding of (1) how HIV can be controlled at entry and after infection in 3 joint sessions with the concurrent HIV Immunobiology meeting, (2) how T cell-based or antibody-based HIV vaccines can be improved, and (3) what are the results of the current vaccine trials and those of alternative methods of HIV or AIDS prevention and how can they help at re-orientating vaccine researches. Two workshops will provide key information on the definition of immune correlates of protection and their analysis in clinical trials."
 
Registration Deadline: 24-Nov-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

HIV Immunobiology: From Infection to Immune Control (X4)

22-Mar-2009 - 27-Mar-2009
Keystone Colorado USA
 
"This meeting will highlight the latest breakthroughs in basic HIV research, ranging from the molecular bases of HIV replication to the host genetic determinants influencing viral spread and disease susceptibility; and from the intricacy of the interaction between HIV and the immune system to the most promising progress in therapeutic development. The meeting will identify new levels of possible intervention to control the progression of HIV-induced disease and, more generally, deepen our understanding of the intimate interaction between retroelements and human hosts. Dynamism will be ensured by having concise, up-to-date talks rather than lengthy lectures, by giving ample room to speakers chosen from the abstracts, and by a close coordination with the concurrent meeting on ""Prevention of HIV/AIDS"". Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting, which will share a keynote address and three plenary sessions with this meeting."
 
Registration Deadline: 24-Nov-2008
http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?Meetin
 
 

Phagocytes: Graduate Research Seminar: Innate Immune Cell: Pathogen Interactions

06-Jun-2009 - 07-Jun-2009
Waterville Valley NH USA
 
Note: This Gordon-Kenan Graduate Research Seminar (GRS) is held in conjunction with the Phagocytes GRC, which starts immediately following the GRS. Those interested in attending must submit a separate application for the GRC, in addition to an application for the associated GRS. Please see the Phagocytes GRC web page for more information.

Phagocytic cells like monocytes, macrophages, and neutrophils, play an essential role in innate immune defense. The Gordon-Kenan Graduate Research Seminar (GRS) on Phagocytes was initiated to provide a unique opportunity for young researchers to share in the Gordon Research Conference (GRC) experience. The two-day GRS immediately precedes the GRC on Phagocytes and is for graduate students and post-doctoral attendees. Young scientists will meet and present their work to each other and some of the leaders in the field, including the Chair and Vice Chair of the Phagocyte GRC, in a quiet and contemplative setting. The theme of GRS is "Innate Immune Cell:Pathogen Interactions".

We anticipate 35-45 graduate students and post-doctoral participants, who are expected to stay for the following GRC. From these participants, twelve speakers will be selected by the organizing committee from the submitted abstracts. We encourage all attendees to present a poster and participate in the poster sessions to be held as part of the GRS. We anticipate having funds to help offset the registration of all 35-45 GRS attendees and some travel costs for the GRS speakers and Discussion Leaders.

The GRS will start on Saturday afternoon and end on Sunday after lunch. Science sessions will be held on Saturday evening and Sunday morning, and a poster session will be held before and after the Saturday evening session. One senior scientist (who is also attending the Phagocyte GRC) and one of the student/postdoctoral invited speakers will serve as Discussion Leaders for the Saturday evening and Sunday morning sessions, respectively.

The deadline for abstract submission to be considered for oral presentation is March 15, 2009. The detailed program for the oral presentations will be posted on the GRS website in April. We encourage you to take this wonderful opportunity to network, to gain experience in presenting your research, and to learn the skills required in facilitating discussion.

Looking forward to meeting you next summer!

 
Registration Deadline: 16-May-2009
http://www.grc.org/programs.aspx?year=2009&program=grad_phago
 
 

Chemical & Biological Terrorism Defense: Integrating "Everyday" With "Maybe Someday"

18-Jan-2009 - 23-Jan-2009
Galveston TX USA
 

The theme of the 2009 Gordon Research Conference on Chemical and Biological Terrorism Defense is Integrating "Everyday" with "Maybe Someday". There are numerous challenges in developing defenses, particularly medical countermeasures, or detection systems, to address biological or chemical threats. If the products or systems address only a particular agent, and have no other application, the cost of development and preparedness is enormously high relative to the perceived benefit of having these tools at hand. This Conference will focus on an array of topics in which new research has been focused on broad spectrum and platform technology approaches to discovering and developing defenses for biological and chemical threats that both leverage and integrate "everyday" applications. Major topic areas will include: broad spectrum approaches to antimicrobials and antiviral drugs; platform technologies for diagnostics; integration of chemical and biological detection into general use platforms; early host responses to biological and chemical agents; translational research: animals to people; "magic bullets": immunomodulators and immune enhancers; "OMICS" for biological and chemical agents; and screening strategies: targets and opportunities for intervention. The Conference will provide a forum for interaction of scientists from a variety of disciplines, and afford an opportunity for junior scientists and graduate students to contribute to a robust interdisciplinary discussion of the topics and challenges presented.

 
Registration Deadline: 28-Dec-2008
http://www.grc.org/programs.aspx?year=2009&program=defense
 
 

Gradient Sensing & Directed Cell Migration

29-Mar-2009 - 03-Apr-2009
Galveston TX USA
 

Gradient sensing and directed cell locomotion, known as chemotaxis, is fundamental to the proper development and functioning of eukaryotic organisms. During early development, chemotactic movements are involved in gastrulation and generation of the trilaminar embryo. Later in development, neuronal guidance is critical for appropriate wiring of the central and peripheral nervous systems. After birth, directed cell migration is critical in normal physiology and in pathology. A crucial function for gradient sensing and directed cell migration is in immune responses. The migration of immune cells through the body during surveillance as well as directed migration towards sites of infection and disease is dependent on chemotactic responses. Chemokines are major regulators of leukocyte migration, and understanding the mechanisms by which their receptors are able to regulate cell motility and direction sensing is critical to understanding how the body enhances and controls immune responses. There are also many pathological examples of gradient sensing and directed cell migration. In the immune system amplified responses to signals can give rise to abnormal inflammatory responses in diverse disorders including asthma and rheumatic diseases. Uncontrolled migration is also a key factor in the progression of cancer. Tumor cells leave original lesions and migrate to distal sites guided by chemoattractants.

There are important parallels between the mechanisms that contribute to cell migration during development, leukocyte trafficking, wound healing and cancer. For many of these conditions, including tumor invasion and metastasis therapeutic options are limited. It is therefore important to have scientists from these diverse disciplines meet to discuss these questions and identify parallel mechanisms that contribute to directed cell migration in diverse systems. This conference will foster new multidisciplinary approaches, and will bring together international leading scientists and young scientists in an atmosphere that encourages scientific exchange.

Planned sessions include (1) Directed cell migration in complex systems, (2) Migration in development and wound healing, (3) Inflammation and leukocyte trafficking, (4) Cell signaling in chemotaxis, (5) Cell polarity and motility in the immune system, (6) Cell polarity and the cytoskeleton in directed cell migration, (7) Modeling and bioengineering in directed cell migration, (8) Directed cell migration in cancer, and (9) Neuronal polarity and growth cone guidance. The combination of speakers and topics has been selected with the specific intention of stimulating new ideas and collaborations in the field of chemotaxis research. The session speakers will emphasize novel unpublished results directly related to gradient sensing and directed cell migration in diverse fields. Young investigators will be encouraged to present and discuss their findings in a supportive environment, by inviting up to 15-20 additional speakers from submitted abstracts and by holding four poster sessions. Scholarships will be offered to encourage participation by young scientists, women and underrepresented minorities.

 
Registration Deadline: 08-Mar-2009
http://www.grc.org/programs.aspx?year=2009&program=gradient
 
 

Apoptotic Cell Recognition & Clearance: Worm-Fly-Vertebrate-Human Clearance And Failure

28-Jun-2009 - 03-Jul-2009
New London NH USA
 

Apoptosis plays a key role in the morphogenesis during development and in the maintenance of tissue homeostasis in adults. Its mechanisms have been intensely studied, and early stages of apoptosis are about to be fully understood. The fate of later stage apoptotic cells remain to be characterized.

The 2009 GRC on Apoptotic Cell Recognition & Clearance will present up-to-date research on the molecular, cellular and immunological aspects of the clearance of dying cells. It will feature a wide range of topics, like tissue homeostasis, stress-response, inflammation, and immunology and will focus on the importance of the clearance of apoptotic cells when investigating development, morphogenesis, tolerance, autoimmunity, and immune privilege. The invited speakers represent a variety of scientific disciplines, including developmental research, genetics, signaling, immunology, medicine, and cell biology. Data on various multicellular organisms from worm to human will be presented. The conference will provide a platform for investigators who are at the forefront of their field, and will welcome junior scientists and graduate students presenting their work in poster format to exchange ideas and hypotheses with leaders in the field. We encourage all poster presenters to give short on-spot talks during extended poster sessions. Some of the posters will also be selected for talks in the main auditory.

The conference provides a forum for:

  • sharing the latest knowledge on fundamental issues how phagocytic cells recognize apoptotic cells and how pathways for the induction of phagocytosis are activated;
  • clarifying implications of apoptotic cell clearance in morphogenesis and homeostasis;
  • understanding recent progress in clinical applications;
  • evaluating topics outside the main issues of this conference;
  • exchanging questions/answers, opinions, ideas and data from ongoing experiments to create collaborations.

The collegial atmosphere of this conference, with opportunities for informal gatherings, promotes cross-disciplinary collaborations in the various research areas represented.

 
Registration Deadline: 07-Jun-2009
http://www.grc.org/programs.aspx?year=2009&program=apoptotic
 
 

Cell-Cell Fusion

19-Jul-2009 - 24-Jul-2009
New London NH USA
 

How and why do certain cells fuse their plasma membranes to form hybrid, multinucleated, or even giant cells? Cell-cell fusion occurs only under special circumstances during the life cycle of any organism. Yet cell fusion is seen in virtually all phyla of eukaryotes. In humans, cell fusions are critical to formation of the new embryo, placenta, muscle and bone, eye, and immune cells. However, we have little understanding of the mechanisms that allow such cells to undergo this profound developmental and cell-biological change, a transition that instantly alters their form, function, and fate.

The Cell-Cell Fusion GRC is a forum where multiple disciplines converge to attack this common problem from their various points of expertise: model biological systems where cell fusion occurs and models of the interactions of lipids and proteins that can lead to membrane bilayer merger. One major goal is to find where these systems share common features - molecules and higher-order structures - and where systems truly diverge, invoking unique approaches to the same ultimate task. Another is to comprehend the functional impact of fusion on the syncytial or hybrid cells that are formed: how polyploid, multinucleate or giant cells benefit survival of the organism. The ultimate goal is to find applications where the control of cell fusion will benefit human health, through controlled fertility, better healing, enhanced immunity, augmented food production, or other means.

The 2009 conference will feature advances in understanding of the diverse biological systems that were presented at the inaugural meeting in 2007, including model organisms where molecular details at the heart of the mechanism have begun to emerge. This meeting will also cover additional species and cell types, other newly found modes of plasma membrane fusion, and more of the physics behind the influence of proteins and lipids on the shape of membranes. Finally, we will learn of novel interventions in medicine where artificial cell fusion may enable treatment of devastating diseases.

 
Registration Deadline: 28-Jun-2009
http://www.grc.org/programs.aspx?year=2009&program=cellcell
 
 

Viruses & Cells

07-Jun-2009 - 12-Jun-2009
Lucca (Barga) Italy Italy
 

The 2009 Viruses and Cells Gordon Conference, the premier conference in the field of virology, will cover all aspects of virus infection, from entry into the cell through replication and assembly, to uncovering the molecular basis of pathogenesis, to prevention and therapy. The 2009 meeting will held at the GRC conference site, Il Ciocco in Barga, Italy from June 7-12, 2009.

The invited speakers will present cutting edge findings on the dynamic interactions of viruses with the cells and organisms they infect as well as host counter responses to infection. Topics will include: entry and receptors; assembly, budding and release, dynamics of cellular trafficking, viral replication & gene expression, immune response & pathogenesis, cellular inhibition of virus replication; innate immune response & virus counter response; exploiting host functions, and epidemiology, prevention & therapy. Discussion leaders, who are expert in the topics covered in each session, will lead lively and open discussions following each presentation. In addition to the invited speakers, shorter talks will be chosen from among the abstracts that are submitted for poster sessions at the time of registration. Selections will be made to highlight exciting new developments in virus research with the emphasis on the selection of younger scientists for these presentations. The evening poster sessions are a prominent and important aspect of this conference providing yet another opportunity for participants to present and discuss their research findings in a congenial atmosphere. The conference will bring together investigators at the forefront of the field, young investigators launching their independent research careers, as well as postdoctoral fellows and graduate students and investigators from industry to discuss new ideas and to foster collaborations.

 
Registration Deadline: 17-May-2009
http://www.grc.org/programs.aspx?year=2009&program=viruses
 
 

Glycobiology

18-Jan-2009 - 23-Jan-2009
Ventura CA USA
 

The 2009 Glycobiology Gordon Research Conference will be held January 18-23 at the Ventura Beach Marriott Hotel in Ventura, California. Please note the earlier date relative to recent years. The Glycobiology Gordon Conference offers a unique opportunity, in a collegial setting, to both contribute to and keep abreast of the latest developments in our multidisciplinary field. Many new glycan functions are rapidly emerging from the studies of tissues and organs of humans and model systems, as well as in the area of parasite-host interactions, and these advances are fueled by equally dramatic developments in glycan structural analysis technologies. Thirteen scientific sessions are currently planned to cover diverse areas of the field, including Structural glycobiology of enzymes and receptors, Mechanisms of glycosylation, Nerve and muscle glycobiology, Chemical glycobiology, Immune cell glycobiology, Vascular glycobiology, Developmental glycobiology, Cancer and cell regulation, Metabolic regulation, and Parasite glycobiology. In addition to the approximately 31 invited talks, ~26 short talks will be selected from poster abstracts, and eight Conference Awards will be available for outstanding abstracts submitted by graduate students, post-docs and new faculty members. All applicants are encouraged to present a poster. The size of the conference has been increased this year to 150 participants but, since registration is limited, early application is advised. We encourage participation of researchers new to the glycobiology field, as well as junior investigators, scientists from developing countries, racial/ethnic minorities, and disabled persons. Please join us for what promises to be an exciting and interactive meeting.

Conference awards will be selected approximately 2 months before the conference (in November), and short talks will be selected approximately 3-4 weeks before the conference (in December). Poster sessions will also be organized at this time by the Poster Chair, Kelley W. Moremen (CCRC, University of Georgia).

For further information contact the Chair:
Christopher M. West
Department of Biochemistry and Molecular Biology
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 USA
Phone: 405-271-4147
FAX: 405-271-3910
Email: Cwest2@ouhsc.edu

 
Registration Deadline: 28-Dec-2008
http://www.grc.org/programs.aspx?year=2009&program=glycobio
 
 

Staphylococcal Diseases

30-Aug-2009 - 04-Sep-2009
Waterville Valley NH USA
 

The 2009 Gordon Conference on Staphylococcal Diseases will present cutting-edge research on S. aureus and coagulase-negative staphylococcus. The Conference will feature a wide range of topics, including the evolution of antibiotic resistance; exoproteins; the immune response to infection; regulatory control mechanisms; biofilm production and metabolism; therapeutics and vaccines; and animal models and virulence. Invited speakers include representatives from both academic and industrial settings who are at the forefront of their field. The Conference will provide opportunities for junior scientists and graduate students to present their work in poster format and exchange ideas with leaders in the staphylococcal field. As usual, selected poster presentations will be selected for short talks. The collegial atmosphere of this Conference, with organized discussion sessions as well as opportunities for informal gatherings in the afternoons and evenings, fosters the development of interdisciplinary collaborations in the various research areas represented.

 
Registration Deadline: 09-Aug-2009
http://www.grc.org/programs.aspx?year=2009&program=staph
 
 

Phagocytes

07-Jun-2009 - 12-Jun-2009
Waterville Valley NH USA
 
Note: A Gordon-Kenan Graduate Research Seminar (GRS) will be held in conjunction with the Phagocytes GRC and will start the Saturday preceding the main GRC. Those interested in attending must submit a separate application for the GRS, in addition to an application for the main GRC. Please see the GRS web page for more information.

Innate immune cells (neutrophils, macrophages, dendritic cells) play an essential role in host defense and inflammation. The theme of this meeting is Innate Immune Cell:Pathogen Interactions. Topics will cover the regulation and molecular basis of the function of these cells with a focus on the impact of their interaction with microorganisms, microbial products, and cytokines. The spectrum of phagocyte function, from diapedisis to phagocytosis and killing, as well as the role of innate immune cell responses to infection in the etiology of acute and chronic diseases, will be included. Invited speakers will be a mixture of leaders in the field and younger scientists, with an emphasis on the latest, most exciting findings. In addition to the invited lectures, there will be poster sessions for attendees to present and discuss their work, which are also a very important component of the meeting. There are slots in the program for late-breaking presentations and shorter talks, which will be selected from abstracts submitted for the poster sessions. We encourage early application for maximum consideration. There will be ample time for discussions and informal interactions among conferees.

We encourage the application and attendance of scientists from a diversity of backgrounds and experience. In particular, women, minorities and younger scientists in the early stages of their careers should consider application, and this Conference has funds to help support registration and travel for these attendees. For those scientists with disabilities, we also have funds to help support any extra costs associated with any special travel arrangements. Please contact the Chair to request consideration for these funds.

Our exciting program is under development and will be posted shortly.

 
Registration Deadline: 17-May-2009
http://www.grc.org/programs.aspx?year=2009&program=phagocytes
 
 

Antigen Cross-Presentation

14-Jun-2009 - 19-Jun-2009
Lucca (Barga) Italy Italy
 

The 2009 GRC-sponsored meeting on Antigen Cross Presentation will present cutting-edge research in the cellular and molecular pathways that regulate the transfer of antigens from the cells of the body to the professional antigen-presenting cells of the immune system. The focus of the conference will span several diverse scientific fields, including cell biology, cell death, dendritic cell biology, protein folding, lipid biophysics, signal transduction, antigen processing and presentation, and imaging. The conference will feature both basic and translational researchers, and will provide opportunities for junior scientists and graduate students to present their work in poster format and exchange ideas with leaders in the field. Some poster presenters will be selected for short talks. The structure of this conference, with programmed discussion sessions as well as opportunities for informal gatherings in the afternoons and evenings, and its remarkable location will provide a unique environment for scientists from different disciplines to brainstorm and promotes cross-disciplinary collaborations in the various research areas represented. Advances in this field will facilitate the strategic manipulation of the immune system in the setting of vaccination, tumor immunotherapy, and chronic viral infections, as well as defining new approaches to the regulation of autoimmunity.

 
Registration Deadline: 24-May-2009
http://www.grc.org/programs.aspx?year=2009&program=antigen
 
 

Carbohydrates

14-Jun-2009 - 19-Jun-2009
Tilton NH USA
 

Carbohydrates are important mediators of many biological processes such as the development and differentiation of cells, cell adhesion and cell signaling, and cell-matrix interactions. Changes either in the structures of these glycans, or in the expression of carbohydrate-binding proteins, are associated with many diseases, including human genetic diseases such as muscular dystrophy or congenital disorders of glycosylation, viral and bacterial infections, parasite invasion and survival as well as metastasis and tumor progression. In addition, glycoconjugates are regulators of the immune system. The main goal of the Gordon Research Conference (GRC) on Carbohydrates is to bring together a diverse group of scientists who work in the broad area of glycoscience (carbohydrate chemistry, carbohydrate biochemistry, and glycobiology) to discuss recent progress and future challenges in the field. The meeting will have talks organized into six focus areas in nine sessions. Two full day symposia will anchor the meeting: synthetic carbohydrate chemistry, and glycobiology. In addition, half-day symposia will be held on: 1) structural biology, 2) renewable resources, 3) glycoengineering and 4) young glycoscientists.

 
Registration Deadline: 24-May-2009
http://www.grc.org/programs.aspx?year=2009&program=carbo
 
 

Molecular Mechanisms of Lymphocyte Differentiation: From Stem Cells to Effector Cells

12-Jul-2009 - 17-Jul-2009
Carefree Arizona USA
 
This meeting covers many aspects of immunology. Sessions covered include:

  • EARLY LYMPHOCYTE PROGENITORS AND LINEAGE COMMITMENT
  • LYMPHOCYTE DEVELOPMENTAL CHECKPOINTS
  • TARGETING AND REGULATION OF V(D)J RECOMBINATION
  • EPIGENETIC CONTROL OF IMMUNE FUNCTION
  • REGULATORY NETWORKS CONTROLLING LYMPHOCYTE DEVELOPMENT
  • PERIPHERAL LYMPHOCYTE DIFFERENTIATION
  • THE GERMINAL CENTER RESPONSE
  •  
    Registration Deadline: 01-Jun-2009
    https://secure.faseb.org/FASEB/meetings/summrconf/selecttopic.aspx?Location1=AZ1
     
     

    HARNESSING IMMUNITY TO PREVENT AND TREAT DISEASE

    11-Nov-2009 - 14-Nov-2009
    Cold Spring Harbor NY USA
     
    We are pleased to announce the Cold Spring Harbor winter biotechnology conference on Harnessing Immunity to Prevent and Treat Disease , which will begin at 7:30 pm on Wednesday, November 11 and run through lunch on Saturday, November 14, 2009. We are looking forward to a broad-based meeting, and abstracts are welcomed on all scientific topics related to the design of novel vaccines, the immune response and delivery systems.
     
    Registration Deadline: 21-Aug-2009
    http://meetings.cshl.edu/meetings/vaccns09.shtml
     
     

    Tackling and imaging the complexity of the immune system

    20-Apr-2009 - 24-Apr-2009
    Capo Caccia IT
     
    EMBO Conference Series (2nd)
     
    http://www.enii.org/index.php?pageId=121
     
     

    Immunochemistry & Immunobiology

    16-May-2010 - 21-May-2010
    Les Diablerets Switzerland Switzerland
     
    There probably is no tissue or organ with a greater impact on human health than the immune system. The last decades have seen an explosion of knowledge regarding the functioning of the immune system both in health and disease.The GRC on Immunochemistry and Immunobiology has been held regularly since 1966. Its small size and broad coverage of cutting edge Immunology distinguish it from larger conferences focussed on more specialised topics within the field. The 2010 GRC on Immunochemistry and Immunobiology will cover those areas of Immunology currently receiving the most intense investigation, both on the basic and applied front. The meeting will be divided into nine half-day sessions, with approximately 36 invited speakers who are internationally recognised for their contributions. Several slots will additionally be allotted for platform presentations selected from submitted abstracts. An intimate setting in the Swiss mountains, ample time for discussion and a maximum of 150 attendees will combine to favour an intense exchange of ideas and to help advance knowledge in the field. As usual, there will be poster sessions and many opportunities for informal interactions among participants throughout the week. Past GRCs on Immunochemistry and Immunobiology have been a great success and the 2010 meeting is likely to be oversubscribed. Early application is highly recommended.
     
    Registration Deadline: 25-Apr-2010
    http://www.grc.org/programs.aspx?year=2010&program=immuno
     
     

    Biology & Pathobiology Of The Cornea

    07-Mar-2010 - 12-Mar-2010
    Ventura CA USA
     
    Vision plays a huge role in the quality of life, and the ocular surface is instrumental in the appropriate refraction and passage of light for normal vision. The cornea is the “window to the eye” and thus as the outermost barrier is uniquely transparent, avascular, and provides 75% of the refractive power of the eye. Unlike other barrier tissues of the body, the cornea and supporting adnexa (eyelids, conjunctiva, meibomian glands, lacrimal glands) have evolved distinctive mechanisms required to maintain transparency and refraction that include the tears, tissue hydration, barrier properties, angiogenesis, biomechanics, and innate and acquired immune response. Disease, injury, surgery, contact lens wear and infections may all adversely affect the delicate balance required to maintain corneal function leading to corneal haze, opacification and blindness. The intent of this Gordon Research Conference is to provide a setting for discussions between researchers, clinicians, clinical fellows, graduate students and postdoctoral fellows with expertise in immunology, microbiology, developmental biology, genetics, genomics, proteomics, vascular biology, biophysics, biomedical engineering, cornea transplant and stem cell biology to push forward the frontiers of cornea research. Anterior eye research has grown tremendously in recent years, and certain areas have become remarkably sophisticated. This conference provides a unique opportunity to bring these groups together to explore corneal function in the context of broader ocular tissues, using cell and molecular biology, imaging, biomechanics, transgenic animal models, gene delivery, microRNA, proteomics, genomics and regenerative stem cell biology. This is a good time to bring these different groups together to compare notes, to collaborate and gain new insights. The sessions will be organized to cover recent advances in ocular surface research, genetic genomic and proteomic approaches, gene regulation by microRNA, barrier functions and secretion, infections, innate and acquired immune response, surgery, biomimetics, stem cell biology and its applications.
     
    Registration Deadline: 14-Feb-2010
    http://www.grc.org/programs.aspx?year=2010&program=cornea
     
     

    Chemotactic Cytokines

    30-May-2010 - 04-Jun-2010
    Lucca (Barga) Italy Italy
     
    It is 20 years since the definition of chemokines as a functionally and biochemically distinct family of proteins. In this time the family has expanded from a small number of members to the current situation where almost 50 chemokines have been identified. In the intervening years much progress has been made in characterising the structure of chemokines, identifying their receptors and the unravelling the complex biologies in which they participate. As a result of these studies it is now clear that chemokines and their receptors are pivotal players in the orchestration of ‘immune’ tissue organogenesis as well as of the innate and adaptive immune responses. Thus chemokine biology now underpins a broad range of biological specialities. Importantly, ‘translational’ studies have provided incontrovertible evidence of the importance of chemokines and their receptors in a range of prominent pathologies. Thus essentially all immune and inflammatory pathologies have, at their heart, a dysfunction of some sort in either chemokine or chemokine receptor expression or responses. In addition, 2 chemokine receptors (CCR5 and CXCR4) have been shown to play profound roles in HIV pathogenesis through their ability to act as co-receptors for viral entry. Finally, details of the roles for chemokines and their receptors in cancer and cancer metastasis have provided important insights into the orchestration of the complex processes of tumorigenesis. Importantly, these pathology-focused studies have highlighted chemokines and their receptors as prominent therapeutic targets and over 10 years of work in this area is now being reflected in a number of chemokine receptor blockers being approved for clinical use. This Gordon Conference will therefore be a celebration of 20 years of research and innovation in the chemokine field. We will explore the complex and diverse biologies of chemokines and their receptors and will integrate this with an up-to-date understanding of the regulation of these molecules. In addition we will examine recent therapeutic developments and will provide updates on the clinical progress of chemokine-based therapeutics. We hope that this will be a forward looking conference with opportunities for in depth analysis of where our field will be heading in the future. Importantly, whilst the science is key to the success of the conference, we will be holding the meeting in Il Ciocco, Italy. This is a beautiful site and the promise of quality red wine and Italian hospitality can only help to make this a successful meeting. We look forward to seeing you in Il Ciocco in May 2010. Gerry Graham and Antal Rot
     
    Registration Deadline: 09-May-2010
    http://www.grc.org/programs.aspx?year=2010&program=chemotac
     
     

    Advances in Molecular Mechanisms of Atherosclerosis

    12-Feb-2010 - 17-Feb-2010
    Banff Alberta Canada
     
    Atherosclerosis, a disease that affects arterial blood vessels, is the major cause of death in developed countries and emerging economies worldwide. The disease is initiated when cholesterol-rich low-density lipoproteins adhere to the walls of arteries, triggering a complex set of reactions involving a variety of cell types including macrophages, endothelial cells, smooth muscle cells, and lymphocytes. This initial lesion progresses to a more complicated atherosclerotic plaque through subsequent cell-cell and cell-lipid interactions that cause chronic inflammation, extracellular alterations, and necrosis. These responses promote plaque disruption, which triggers acute thrombosis resulting in vascular occlusion and myocardial infarction. The goal of this meeting is to provide attendees with the latest advances in the understanding of cellular processes that contribute to atherosclerosis, with particular emphasis on cholesterol metabolism and foam cell formation, genetics, and the immune system. These goals will be significantly enhanced by holding the meeting concurrently with the proposed meeting, ムThe Macrophage: Intersection of Pathogenic and Protective Inflammation'. In addition to four atherosclerosis-specific plenary sessions, four joint sessions are planned to highlight major developments in areas of mutual interest to investigators in the fields of atherosclerosis and macrophage biology. Elucidation of mechanisms underlying development of atherosclerosis may reveal new therapeutic strategies to combat the disease. This program will stimulate interactions that are likely to augment and accelerate this process.
     
    Registration Deadline: 12-Feb-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1034&subTab=summary
     
     

    Lymphocyte Activation and Gene Expression

    27-Feb-2010 - 04-Mar-2010
    Breckenridge Colorado USA
     
    Lymphocytes mediate the adaptive immune responses to antigens derived from infectious agents, transformed cells, transplanted organs and, in the setting of autoimmunity, ones own cells. The study of lymphocyte activation and gene expression is central to understanding the complex biology of these cells and offers hope for regulating these cells in different clinical settings. Much has been learned in the past several decades in this field. Receptors, enzymes and adapter molecules have been identified, signaling cascades and networks have been defined, and the complex regulation of gene expression has been explored. Nonetheless many basic questions remain to be elucidated. Among several contentious areas of research that will be presented by experts at this meeting are the actual means by which antigen receptors initiate the activation process, how activation induces changes in signaling pathways, intracellular organelles and the cytoskeleton, and how changes in chromatin and transcriptional factors determine gene expression.
     
    Registration Deadline: 27-Feb-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1047&subTab=summary
     
     

    Innate Immunity: Mechanisms Linking with Adaptive Immunity

    07-Jun-2010 - 12-Jun-2010
    Dublin Ireland Ireland
     
    In the past 5 years there have been remarkable advances in our understanding of the molecular basis of innate immunity. We now have considerable detail on the major classes of innate immune receptors that sense pathogens and provoke immune and inflammatory responses. These include the Toll-like receptors (TLRs), NOD-like receptors (NLRs) and RIG-I-like receptors (RLRs). The role these receptors play in host defense against microbes has been studied, their signaling pathways elucidated, and their roles in infectious and inflammatory diseases examined in detail. As well as stimulating innate immunity via induction of various effector mechanisms, these receptors also participate in the establishment of adaptive immunity. This occurs via the induction of key cytokines to promote T and B cell development and activation, and also via the induction of co-stimulatory molecules on the surface of dendritic cells, notably CD80 and CD86. A final aspect concerns adjuvancy ヨ microbial or synthetic agents that activate these receptors act as powerful adjuvants required for the establishment of memory responses. This conference will bring together scientists working on innate immune mechanisms activated by these receptors, and will have as a key focus the ability of these receptors and the responses they elicit to promote adaptive immunity. The conference will therefore be of interest to many investigators interested in immunity and the role the immune system plays in disease.
     
    Registration Deadline: 07-Jun-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1046&subTab=summary
     
     

    Role of Inflammation in Oncogenesis

    07-Feb-2010 - 12-Feb-2010
    Keystone Colorado USA
     
    Cancer is characterized by accelerated and uncontrolled growth, dysregulation of apoptosis, invasion and metastasis. While genetic and epigenetic mechanisms may underlie transformation, the tumor microenvironment promotes the neoplastic process. Chronic inflammation and infection, in particular, are linked to the development of cancer. Examples include the association between inflammatory bowel disease and colon cancer, Helicobacter pylori infection with gastric cancer and HPV with cervical cancer. Recent studies have linked the innate immune system, through production of inflammatory cytokines, with cancer progression. Factors such as TNF alpha, IL-6, and TGF beta, produced by macrophages and dendritic cells amongst other cells, enhance tumor growth, invasion, metastasis, and angiogenesis, while simultaneously impairing anti-tumor immune mechanisms. There have been several advances in our understanding of the influences of inflammation on tumorigenesis. However, critical elements of the involved inflammatory pathways that modulate tumor progression still remain to be identified. The complex interrelationship between inflammatory vs. immune suppressive cytokines and their effects on the neoplastic process remain to be defined. The association between DNA damage and inflammation and the link between pathogen associated molecular patterns (PAMPs) and novel pattern recognition molecules (TLRs and NOD like receptors) in driving tumor development require further characterization. How cancer associated inflammation might actively dysregulate the innate immune system, in particular of dendritic cell, NK and NKT cell anti-tumor function, is also an area of interest and intense speculation. This meeting will focus specifically on mechanisms of inflammation-induced carcinogenesis, and will bring together investigators with diverse interests and expertise - immunology, signal transduction, cancer biology and therapeutics. It is anticipated that the pairing with the concurrent Keystone Symposia meeting on Immune Escape in Cancer will attract a large body of scientists who share a common interest in cancer pathogenesis, inflammation and mechanisms underlying immune evasion. The goal of the meeting is to enhance discussion, foster collaborations, report on new paradigms, and ultimately to develop approaches that will modulate inflammation-associated tumor progression.
     
    Registration Deadline: 07-Feb-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1028&subTab=summary
     
     

    Alzheimerメs Disease Beyond Abeta

    10-Jan-2010 - 15-Jan-2010
    Copper Mountain Colorado USA
     
    By 2010 many of the clinical trials presently underway targeting Abeta will have been completed or far enough along the pathway that we will have a better understanding of the benefit and limitations of this approach. This leads us to consider what are the next targets that will need to be addressed to fully treat and prevent Alzheimerメs disease. The objective of the planned meeting is therefore to stimulate and promote a discussion beyond Abeta as a key factor and therapeutic target in Alzheimer's Disease. This objective will be equally important whether therapeutic approaches targeting Abeta are successful or not, to either complement and expand successful Abeta therapies or to initiate a paradigm shift. In particular, we would like to discuss the generation of alternative models to study Alzheimer's Disease, and highlight several exciting areas of research including the role of synaptic dysfunction, neuronal regeneration, the immune system, and protein degradation in Alzheimer's Disease.
     
    Registration Deadline: 10-Jan-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1052&subTab=summary
     
     

    HIV Biology and Pathogenesis

    12-Jan-2010 - 17-Jan-2010
    Santa Fe New Mexico USA
     
    The Keystone Symposia Meeting on HIV Biology and Pathogenesis emphasizes key aspects of the basic virological, cell and molecular biological, and disease aspects of HIV. The focus will be to highlight recent advances in our understanding of HIV/AIDS ranging from the earliest events of transmission, to treatments for infected individuals, to interventions to prevent viral transmission. The goal of the meeting is to emphasize the basic mechanisms of viral replication and the interplay of the virus with the immune system leading to the development of AIDS.
     
    Registration Deadline: 12-Jan-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1053&subTab=summary
     
     

    Viral Immunity

    21-Mar-2010 - 26-Mar-2010
    Banff Alberta Canada
     
    The most exciting recent advances in viral immunity include the increased understanding of the role of innate immune mechanisms, interaction between innate and adaptive immunity, pathogen manipulation of host responses, and activation of immune responses and generation of immune memory. Despite these advances, basic mechanisms of anti-viral immunity are poorly characterized particularly for chronic infections. Efforts are also required to exploit recent research advances to improve vaccine design and therapeutic intervention. This meeting will include both innate and adaptive immunity and juxtapose animal models with human studies as it attempts to foster collaborative efforts between attending viral immunologists and the HIV vaccine researchers in the joint meeting. Expert talks in plenary sessions will encompass the latest in critical areas of viral immunity. Workshops and additional presentations will cover provocative and cutting-edge results from attendees. The meeting objective is to accelerate progress in understanding and manipulating anti-viral immunity to improve human health.
     
    Registration Deadline: 21-Mar-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1050&subTab=summary
     
     

    Human Immunology and Immunodeficiencies

    12-May-2009 - 17-May-2009
    Beijing China China
     
    The study of human immunodeficiency, whether inherited or acquired, is an outstanding and illuminating approach for the understanding of human immunology. The clinical investigation of these experiments of nature provide novel insights into the physiology of immune responses. In the course of this Keystone Symposia meeting we aim to bring together experts in the three related fields of primary immunodeficiencies, complex genetics of infectious diseases, and virus-induced immunodeficiency. The immunological and clinical lessons learned from the care and investigation of patients with these conditions will be discussed.
     
    Registration Deadline: 12-May-2009
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1021&subTab=summary
     
     

    Molecular and Cellular Biology of Immune Escape in Cancer

    07-Feb-2010 - 12-Feb-2010
    Keystone Colorado USA
     
    It is now widely recognized that the immune microenvironment of a tumor provides critical support in determining its progression versus dormancy or destruction. To gain immune benefits the tumor must evolve mechanisms of immune escape. Study of this crucial process requires cross-fertilization between molecular cell biologists and tumor immunologists who do not tend to interact. This problem is also integrated with the problem of cancer inflammation that has captured the attention of tumor biologists focused on transgenic mouse models and clinical settings. Thus, we propose a unique conference ヨ the first of its kind ヨ to integrate perspectives from a diverse set of researchers in cancer, immunology, and molecular therapeutics and to focus specifically on immune escape and tumor-induced immune suppression as a multidisciplinary problem. Cancer is initiated by the accumulation of genetic and epigenetic changes in a normal cell, but its progression depends on the stromal and immune microenvironment of the initiated cell. While intrinsic signals within the initiated cell drive neoplastic transformation and genomic plasticity, extrinsic signals delivered by immune cells are critical in dictating whether progression versus dormancy or destruction of an initiated lesion takes place, and also whether metastasis may occur. The high degree of genomic plasticity in cancer cells permits them to develop sophisticated ways to prevent the immune system from recognizing and eliminating tumor cells. It has become increasingly clear in recent years that abnormalities in the immune system that are induced by tumors not only hamper natural anti-tumor immune surveillance but also limit the efficacy of immunotherapy and even traditional chemotherapy and radiotherapy. Thus, tumor-induced immune abnormalities may not only impact the clinical course of disease but also the prospects for its therapeutic management. Recent results indicate that we are on the verge of a real breakthrough in our understanding of how tumors thwart the immune system and how correcting immune escape could vastly improve cancer therapy. However, at present the available mechanistic information presents a somewhat convoluted picture that includes some seemingly contradictory elements. While this situation is a natural stage of development in the field, there is nevertheless a pressing need to define key questions and organize their development in coherent ways that can speed improvements in cancer therapy.
     
    Registration Deadline: 07-Feb-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1038&subTab=summary
     
     

    Cell Death Pathways: Apoptosis, Autophagy and Necrosis

    12-Mar-2010 - 17-Mar-2010
    Vancouver British Columbia Canada
     
    Homeostatic and pathological cell death can occur through a multiplicity of different mechanisms including apoptosis, autophagy, necrosis and others. The morphological and functional definitions of distinct cell death modalities are emerging, and the relationships between different lethal pathways are being determined. However, the exact nature of the molecular switches that determine which subroutines cells disintegrate are elusive. Moreover, the relative contributions of different cell death modalities to the avoidance of cancer or degenerative diseases remain to be defined. In cancer, in particular, where defects in cell death are prevalent and the survival of undead cells enables progression and treatment resistance, restoration of cell death pathways is an important and achievable therapeutic goal. Finally, distinct cell death modalities may remain immunologically silent or trigger an immune response, through mechanisms that are still elusive. The 2010 Keystone Symposia meeting on Cell Death will address the normal regulation and pathogenic dysfunction of distinct cell death modalities, present new strategies for therapeutic cancer cell induction and address the immunogenicity of distinct cell death types.
     
    Registration Deadline: 12-Mar-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1040&subTab=summary
     
     

    Overcoming the Crisis of TB and AIDS

    20-Oct-2009 - 25-Oct-2009
    Arusha Tanzania Tanzania
     
    Tuberculosis (TB) is the largest cause of death in the AIDS setting, having caused approximately 50% of all AIDS deaths globally. Each infection on its own manipulates the host immune response to enhance the other infectionメs pathogenicity, and the treatment of each involves long or lifelong therapy of complicated drug regimens. The focus of this Keystone Symposia meeting is to gain deeper insights into the immune pathology and deadly synergism between HIV and TB and its global toll in order to identify new ways to solve this global catastrophe by way of basic scientific discovery, and the development and delivery of vaccines, drugs and care. Mycobacterium tuberculosis survives in the vast majority of infected individuals without causing disease. However, as HIV compromises the immune system it fuels clinical emergence of TB and, as a result, has become the driving force for the current TB epidemics in Subsaharan Africa and Asia. TB in turn drives HIV-1 replication and causes HIV-1 disease progression. In order to effectively tackle this twin epidemic, integrated approaches encompassing basic immunological research, drug discovery, drug and vaccine design and delivery and novel approaches to delivering care in remote and impoverished areas must be integrated. This includes the following: virologic and bacteriologic research on the pathogens themselves; immunologic, molecular and cellular research on the host response; design, development and delivery of drugs and vaccines; development of different technologies for biomarkers of disease and cure; and novel drug and vaccine delivery systems. Moreover, basic discovery must be synergized with novel approaches to the delivery of TB and AIDS care in endemic areas. The overarching goal of the symposium is to gain a broad perspective on the problem of TB/AIDS ヨ from its impact on life on earth to the basic biology of the organisms, the immune response ヨ and to develop new paradigms of thinking and responses to deal with the humanitarian catastrophe of TB and AIDS co-infection.
     
    Registration Deadline: 20-Oct-2009
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1022&subTab=summary
     
     

    HIV Vaccines

    21-Mar-2010 - 26-Mar-2010
    Banff Alberta Canada
     
    Traditionally, the Keystone Joint HIV Symposia have integrated vaccines and pathogenesis to comprehensively cover the fieldラfrom HIVメs fundamental biology to its interaction with the human immune system and how to design a vaccineラand these Joint Symposia have been convened every year. In addition to this Keystone Joint Symposium, there are a couple of other well-established HIV vaccine meetings in the year (CROI and the AIDS Vaccine Conference) that follow a similar format and also often feature a similar line-up of speakers. Since an HIV vaccine is proving to be a particularly recalcitrant problem, a novel approach that facilitates a wider cross-fertilization of ideas would be very valuable and would be welcomed by the broader HIV vaccine research community. To that end, the major development proposed for the 2010 Keystone HIV Vaccine Symposium is to foster innovative ideas and new collaborations with immunology and vaccinology as it pertains to other viral diseases. Specifically, we propose that a new Joint Symposium of HIV Vaccines in conjunction with Viral Immunity be convened. This Joint Symposium would retain the valuable format that includes joint and separate sessions covering general and specific principles.
     
    Registration Deadline: 21-Mar-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1051&subTab=summary
     
     

    NF-kappaB in Inflammation and Disease

    05-Jan-2010 - 10-Jan-2010
    Santa Fe New Mexico USA
     
    In the past 10 years, impressive progress has been made on how the NF- kappaB transcription factor is regulated and how diverse signals frequently use ubiquitin-dependent mechanisms to activate NF- kappaB. Many of the signal transducers and regulatory enzymes have been identified and their essential roles in NF- kappaB regulation revealed through genetic analyses in mice. More recent work highlights the importance of NF- kappaB in innate immune signaling by cell surface Toll-like receptors and cytosolic Nod-like receptors. Although current research clearly implicates NF- kappaB in diabetes, inflammatory diseases and cancer, a challenge for the future will be to reveal the precise molecular and cellular mechanisms of NF- kappaB dysfunction in disease. The realization that NF- kappaB activity is regulated by kinases and ubiquitin modifying enzymes presents multiple opportunities for therapeutic intervention. In addition to highlights from basic research, results from clinical trials using IKK and other NF- kappaB inhibitors are expected to be presented at this meeting.
     
    Registration Deadline: 05-Jan-2010
    http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1023&subTab=summary
     
     

    Antimicrobial Peptides

    15-May-2011 - 20-May-2011
    Lucca (Barga) Italy
     
    Antimicrobial peptides (AMPs) are host-defense molecules produced by all living organisms, including bacteria, fungi, plants, invertebrates, vertebrates as well as humans. These molecules represent effectors of the metazoan innate immune system as well as defense molecules of microbes. In multicellular organisms they act at the front line of the defense system against pathogens where they are synthesized constitutively or inducibly at epithelial surfaces, the location where the initial contact with all microbes, from symbionts to pathogens, takes place. There is now evidence that these peptides represent key components at epithelial surfaces, the barrier between the external environment and the interior milieu, where they play an important role in defining the composition of microbiota and its interaction with the host.
     
    Registration Deadline: 17-Apr-2011
    http://www.grc.org/programs.aspx?year=2011&program=antimicro
     
     

    Cartilage Biology & Pathology

    06-Mar-2011 - 11-Mar-2011
    Ventura CA USA
     
    The 2011 Gordon Conference on Cartilage Biology and Pathology will present cutting-edge research on the molecular and cellular aspects of cartilage formation, maintenance, repair and disease. Topics for discussion have been selected with a view to balance translational and basic research and to stimulate work related to repair, and regeneration geared toward major diseases of cartilage. The Conference program covers areas of active research and includes progress in understanding cartilage evolution and development, signaling mechanisms in chondrocytes, growth plate, and articular cartilage, genetic mechanisms of cartilage disease, metabolic and immune influences on cartilage, degenerative cartilage disorders, and repair, regeneration and tissue engineering strategies in disorders of cartilage. The last session of the meeting will be devoted to research that defines new directions and technologies, challenges and opportunities.
     
    Registration Deadline: 06-Feb-2011
    http://www.grc.org/programs.aspx?year=2011&program=cartilage